Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fused in sarcoma (FUS), also known as RNA-binding protein FUS or translocated in liposarcoma (TLS), is a multifunctional DNA/RNA binding protein. It plays critical roles in various aspects of gene expression and genome maintenance, including transcription regulation, alternative splicing, mRNA transport, and DNA repair. FUS was first identified as part of an oncogenic fusion protein resulting from chromosomal translocation t(12;16)(q13;p11) found in human myxoid liposarcomas, and mutations/misregulation are implicated in several neurodegenerative diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fused in Sarcoma (FUS).